Possible serotonergic mechanisms underlying the antidepressant and anti-obsessive-compulsive disorder responses

被引:142
作者
Blier, P [1 ]
de Montigny, C [1 ]
机构
[1] McGill Univ, Neurobiol Psychiat Unit, Montreal, PQ H3A 1A1, Canada
关键词
serotonin reuptake inhibitors; monoamine oxidase inhibitors; tricyclics; autoreceptors; pindolol;
D O I
10.1016/S0006-3223(98)00114-0
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Considerable evidence is now available to support the pivotal role of the serotonin (5-HT) system in exerting the antidepressant response in humans. Different types of antidepressant treatments enhance 5-HT neurotransmission via different pre- or postsynaptic mechanisms. The time course for the occurrence of these adaptive changes in the brain of laboratory animals is consistent with the delayed onset of the antidepressant response in humans. The drugs effective in obsessive-compulsive disorder (OCD) also enhance 5-HT neurotransmission in brain regions involved in mediating OCD symptoms but with a more prolonged delay, consistently with the longer time necessary to obtain an optimal therapeutic effect in OCD than in depression. The elucidation of these mechanisms of action lead to the development of new pharmacologic strategies to potentiate the therapeutic effect of the drugs currently available and to the identification of novel targets to accelerate and further improve treatment response in depression and OCD, (C) 1998 Society of Biological Psychiatry.
引用
收藏
页码:313 / 323
页数:11
相关论文
共 61 条
[21]  
DELGADO PL, 1997, EUR J NEUROPSYCHO S2, V7, P577
[22]   LITHIUM ADDITION IN TREATMENT-RESISTANT DEPRESSION [J].
DEMONTIGNY, C .
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 1994, 9 :31-35
[23]  
DEMONTIGNY C, 1984, J PHARMACOL EXP THER, V228, P230
[24]   In vivo electrophysiological characterization of 5-HT receptors in the guinea pig head of caudate nucleus and orbitofrontal cortex [J].
ElMansari, M ;
Blier, P .
NEUROPHARMACOLOGY, 1997, 36 (4-5) :577-588
[25]   ALTERATION OF SEROTONIN RELEASE IN THE GUINEA-PIG ORBITOFRONTAL CORTEX BY SELECTIVE SEROTONIN REUPTAKE INHIBITORS - RELEVANCE TO TREATMENT OF OBSESSIVE-COMPULSIVE DISORDER [J].
ELMANSARI, M ;
BOUCHARD, C ;
BLIER, P .
NEUROPSYCHOPHARMACOLOGY, 1995, 13 (02) :117-127
[26]  
ELMANSARI M, 1997, SOC NEUROSCI, V23
[27]   5HT-2 RECEPTOR AND FLUVOXAMINE EFFECT IN OBSESSIVE-COMPULSIVE DISORDER [J].
ERZEGOVESI, S ;
RONCHI, P ;
SMERALDI, E .
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 1992, 7 (04) :287-289
[28]  
Fabre Jr L. F., 1990, J CLIN PSYCHOPHARM, V10, p67S
[29]  
GOODMAN WK, 1989, ARCH GEN PSYCHIAT, V46, P36
[30]  
GREENBERG B, 1994, NEUROPSYCHOPHARMACOL, V10, pS265